Amgen
NPLATE
Manufacturer:
Amgen
Name:
NPLATE
HCPCS Code Descriptor:
Injection, romiplostim, 10 micrograms
Category:
J Code
HCPCS:
J2796
NDC(s):
55513-0221-01, 55513-0222-01, 55513-0223-01
Primary Type:
Oncology Colony Stimulating Factor
Generic Status:
Single-Source
Route of Administration:
Subcutaneous
About:
NPLATE is an Oncology Colony Stimulating Factor drug manufactured by Amgen and administered via the Subcutaneous route of administration. The J Code: J2796 is aligned to the drug NPLATE.
Access Pricing and More By Registering
HCPCS Added Date:
1/1/10
HCPCS Effective Date:
1/1/10
HCPCS Short Description:
Romiplostim injection
Billing and Coding Guide:
https://www.nplatehcp.com/itp-resources/-/media/Themes/Amgen/NplateHcp-com/Nplatehcp-com/images/nplatehcp/docs/nplate-physician-coding-and-billing-guide-pdf-pdf.pdf
Patient Assistance:
http://www.amgensafetynetfoundation.com
https://www.amgenassist.com/copay